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Introduction 
 
Research was undertaken in response to requests by older people 
in Rochdale Borough to investigate an issue of great concern to 
them namely prescription medications constantly changing 
appearance due to generic prescribing. When branded drugs are 
still in their ‘patent’ period, which is a number of years after they 
are introduced into the market, there is only one sole supplier. 
Expiration of this period allows other manufacturers to ‘mimic’ the 
branded product, at a fraction of the cost. It is an NHS directive for 
prescribers to use the generic drug name when a drug is 
prescribed unless there is a clinical justification for using the brand 
name.  
When people receive their tablet medicines from their pharmacist, 
the brand and so the appearance (colour, size, shape) can be 
vastly different to those dispensed following their previous 
prescription despite having the same active ingredient. This is 
often due to a lack of standardisation practice required amongst 
manufacturers. Drugs are made to British and European 
Pharmacopoeia standards but these do not specify colour, size 
and shape. Medicines are required to be of 'essential similarity' but 
that does not include appearance. Many pharmacists believe that 
standardisation, should not only include size, shape, colour but 
also packaging. Packaging changes from the same company on 
consecutive orders presents considerable challenge to 
pharmacists as well as patients. 
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Older people from Rochdale User Carer Action Forum initially 
suggested the topic of changed appearance of medications as a 
focus for research. They provided anecdotal evidence of the 
problems experienced by some older people as a result of frequent 
changes in size, colour and shape of tablet medications in 
particular. They reported that these changes had caused some 
older people anxiety, confusion and distress. They also believed 
some drug errors were occurring with a risk of hospitalisation as a 
result.  In response, an initial survey funded by the University of 
Salford was undertaken with 2000 older people across Greater 
Manchester which supported many of these claims (Williamson et 
al 2009) [available from http://usir.salford.ac.uk/2989/]. Funding 
was found from the Greater Manchester Primary Care Trust 
Alliance through the Older People’s Network to support a 
qualitative study to gain deeper insights into the problems of 
changed medication appearance. Older people from the Rochdale 
User Carer Action Forum acted as study advisors.   
The study 
The aims of the study were: 
 
1. To design a qualitative study in partnership with older people 
to elicit older people’s experiences in relation to changed 
medication appearance  
2. To identify any impact on older people’s personal approach 
to medication management as a result of changed 
medication appearance 
 
The study was a patient experience study as opposed to a study of 
pharmaceutical or prescribing practices.  
Following recruitment undertaken at the same time as an earlier 
survey (Williamson et al 2009), 32 participants taking three or 
more prescribed tablet medications and aged between 62 and 88 
years of age from across Greater Manchester, expressed an 
interest in being interviewed about their views of changed 
medication appearance. Interviews were face-to-face and digitally 
audio recorded with almost half being video recorded. Participants 
were an almost even mix of men and women.  
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Findings 
After careful thematic analysis, three categories and one core 
category emerged from the data. These are the importance of 
routine, confidence, being old and a core category of retaining 
control. The categories illustrate the concerns raised by 
participants surrounding the impact of changes in medication 
appearance on their medicines management. The categories 
highlight their need for maintaining routine and the impact of 
appearance changes on confidence at a personal level, in others 
(health care professionals) and with the medications themselves. 
Participant’s held shared perceptions about ‘being old’ and how 
these influenced their management of the appearance changes. 
The core category of retaining control is reflected throughout all 
other categories and illustrates how participants seek to maintain 
stability with their medicines management through such measures 
as avoidance of changes in appearance or by adapting to change 
through information.  
Findings revealed that these older people were challenged by the 
changes in their medications which impacted on their confidence 
and forced them to repeatedly double check their medicine 
regimes. The older people we interviewed felt they were only able 
to cope with the changes in medicine appearance due to their own 
diligence and because they had capacity to do so. Most were very 
concerned that as they became older and their capacity to self-
manage medicines reduced, that they would be at risk of 
medication errors. They also believed there were many older 
people less capable than themselves who were already struggling 
to cope with medicine appearance changes.  
One participant said “You wouldn’t buy an orange cabbage would 
you?” to illustrate how disconcerting they found changes to their 
established medicines.  
The importance of routine: 
In nearly all cases participants had a regimented routine which 
they maintained despite any medication changes. Their routine 
was the bedrock of their medication management and provided a 
‘security blanket’ which they used to help remain in control of their 
tablets. Any change to medication appearance threatened this 
position and prompted participants to reassess their medications 
and question or double check their routine. Thus the impact of the 
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appearance changes varied. From the outset, it became evident 
that although the participants generally felt that they had little or no 
actual problems as a result of the changes, they had impacted on 
their daily medication administration in a number of ways. Many 
had to double check their tablets and some felt the need to contact 
the pharmacist or GP about them whilst a number of participants 
questioned the rationale for the changes. Their main concerns 
related to colour change. Some felt that the size, accessibility of 
packaging and naming of the tablets was frustrating. Generally, the 
participants said that they managed the changes satisfactorily but 
were clearly tired of keeping up with the frequency of the changes 
they experienced.  
In all cases, the participants demonstrated how they managed 
their tablets through complex administration systems, through to 
simple cardboard boxes and counting out morning, afternoon and 
evening tablets. The range of routines displayed throughout the 
project was extensive and many participants prided themselves on 
their control and organisation of their medication. As can be 
expected, those with more medications to take than others found 
appearance changes more challenging. 
Changes in colour 
Changes in medication colour were by far the most common 
changes noted by the participants. Although many did not refer to 
these as major problems they did confess that these changes 
cause some concern. Interestingly, colour was viewed as a 
particularly important factor in the management and control of self-
administered medication. For many, colour was used to denote a 
particular tablet – for example, some participants referred to “I take 
the blue one first and then the pink”. 
 
Changes in shape 
With nearly all participants, a good routine was essential in 
order to maintain their medicines management. Shape was 
important in recognising tablets but not as much as colour. 
 
Changes in packaging 
Whilst the focus of this study is on appearance of medications 
themselves, some participants raised changes in appearance of 
packaging as an issue. Some packets changed to have similar 
colours and shape to others which again made it difficult for the 
participants to discern one medication from another 
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Managing access 
In some cases, participants reported difficulty in physically 
accessing their tablets due to a change in the cover of the tablets. 
For those participants with arthritic thumbs access to some tablets 
was especially difficult. Others dropped tablets as they were 
considered ‘fiddly’.  
 
Confidence: 
Confidence became a significant category and was broken down 
into three sub categories. 
 
Confidence in self 
Over the duration of the study, it became apparent that the 
participants needed to be confident in a range of areas. The 
frequent changes in medication appearance hampered their 
confidence that they had previously formed through their 
medicines management routine, knowledge of medication and 
confidence in health professionals. For some, loss of confidence 
also extended to their beliefs about the quality and effectiveness of 
a drug. These different sources of reduced confidence 
compounded to reduce self-confidence generally. 
 
Confidence in others  
For the vast majority of participants, any medication changes could 
be readily checked with the pharmacist or the GP. Most of the 
participants felt confident in contacting their GP or pharmacists for 
advice. The helpfulness of pharmacists in relation to responding to 
queries was strongly evident across most of the interviews. Some 
participants did not check any changes with health care 
professionals because they had faith in their GP and were 
confident that the tablet content would be the same. Participants 
warned that not all older people physically went into a pharmacist 
nor were able or comfortable in using a telephone to gain advice 
from a pharmacist, and so may miss out on support. 
 
Some participants stated that their medications had often changed 
as a result of attending a different pharmacy. In these cases, the 
tablets changed depending on what type the differing pharmacies 
dispensed. This caused some of the participants to go elsewhere 
for their medication although most were happy with the 
pharmacists and continued with the same pharmacy. 
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Only one participant stated that they had been contacted prior to a 
change in medication appearance although many did suggest that 
information provision and being alerted to any changes would have 
been useful and allayed some of their initial anxieties.  
 
Confidence in medications 
On the most part participants recognised a need for the NHS to 
reduce costs and manage its pharmacy services cost-effectively 
and this helped them to accept any medication appearance 
change. Some participants (n=8) however questioned the quality of 
the medication and felt that reduced cost meant that the tablets 
may not be as effective. Whilst this didn’t deter these participants 
from taking the medications it did reduce their confidence in them 
and two participants stated that they had noticed a change in the 
effect of their tablets. Confidence with the tablets was implied in 
nearly all of the interviews and was seemingly underpinned by 
participant’s familiarity with the tablets they were taking. Thus any 
changes to the tablet affected this confidence.  
 
Being ‘Old’: 
A further category that arose was that of ‘being old’. Participants 
were keen to share their views about control and management of 
their medications, but wanted also to highlight their concerns for 
themselves and others. Whilst for many, the repeated medication 
appearance changes were manageable, many harboured 
significant concerns that as their age progressed, they would likely 
experience a loss of physical ability that would eventually 
compromise their ability to manage their tablets. 
 
Any future changes in medication appearance were therefore 
recognised as potentially detrimental to participant’s progress and 
health. This concern was reflected by most of the participants. 
Whilst keen to refute any negative effects of older age currently, 
these participants acknowledged some sense of inevitability of loss 
of physical ability at a later date. This raises questions about how 
at risk people will be recognised and helped to manage medication 
changes. 
 
Retaining control: 
Ultimately, the categories revealed a commonality amongst all of 
the participant’s stories. The ways in which the changes in 
medication appearance had potentially disempowered them was 
quite striking. Almost all of the participants prided themselves on 
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their ability to manage and self-administer their medication and 
despite the appearance changes, they were able to do this 
because of a good routine and physical and mental capacity. To 
some extent, they all remarked on how this helped them remain in 
control of their tablets, rather than the tablets controlling them. In 
some respects, being in control of their medications went some 
way to busting the myth that they were ‘old’ or that they could be 
classified as such in an ageist way. For them, ‘old’ was a 
derogatory word which meant decline and dependence.  
 
Participant’s methods for maintaining control echoed the ways they 
managed their tablets. All the regimens varied. Some kept their 
tablets in the original containers whilst others re-dispensed their 
medication into boxes, old margarine tub’s, Dosette boxes (a 
monitored dosage system) and small coloured containers. Some 
had an array of tablets spilling out from an undersized cup or box. 
It was obvious that all the approaches worked sufficiently well for 
the individuals using them – despite the outward appearance of 
some of them being in a jumble. This was made possible because 
of the person’s familiarity with the medication, confidence in the 
tablets, faith in the health professionals and subsequent control 
over the medications. Thus any changes were managed 
accordingly so that they did not disrupt the established routine.  
 
Whilst few known medication errors were divulged by this group of 
participants, the risk for these is evident in the way that 
participants tailored their medicines management. These bespoke 
storage, labelling and administration solutions may not be what 
health professionals would advocate not least as they introduce 
room for error such as when participants decanted tablets into 
unmarked containers. However, for participants, disruption of an 
established routine such as when medication appearance 
changes, similarly introduces opportunity for mistakes of varying 
severity. 
 
Discussion & Conclusions 
 
Three categories and an overarching core category emerged from 
the data. Those interviewed generally did not find that medication 
appearance change caused them major difficulty because they 
were able to manage the changes competently. Participants were 
very clear that changes in appearance did cause them significant 
concern and in some cases anxiety for a number of reasons. More 
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importantly, those interviewed considered themselves not to be 
those most at risk from the changes as they had established their 
own informal medicines management approaches which generally 
worked for them. Participants were concerned for others who may 
be less competent and able than them. Participants did feel a 
number of their peers were at significantly more risk than them and 
that the experiences of these other older people require further 
investigation.  
 
Participant’s main concern was about the potential for them to lose 
capacity to manage their medicines in later life and how this would 
be identified as well as concern for those already with reduced 
capacity who may be being overlooked by health professionals 
who could address any risk.  
 
Medication appearance changes compromised participant 
confidence at a personal level, with health professionals and in the 
medications themselves. Most felt they could overcome this 
reduced confidence by having routines that kept them in control of 
their regimes, by seeking advice and by reading routine or 
bespoke information about their medications. Participants agreed 
that high standards of practice by pharmacists should be 
encouraged to: avoid changes in appearance where possible; to 
notify people of changes where reasonable; and to avoid changes 
with those most at risk of being mal-affected by any changes. 
Further and better quality written information is also indicated as 
these participants found instruction leaflets to be unhelpful whilst 
information sheets that accompany Dosettes issued by a 
pharmacist were considered to be very useful. Some would have 
preferred both kinds of information. Further work to engage with 
older people and perhaps develop information materials that meet 
their needs is indicated.  
 
The widespread use of Dosette boxes purchased by participants 
without prompt from a health professional is suggestive that older 
people are feeling in need of support with their medication taking 
and is perhaps an early indicator of them having such a need.  
Whilst Dosettes issued by a pharmacist follow an assessment of 
need, those bought by individuals from high street shops do not 
and a Dosette box may not be the best solution for that individual’s 
needs. This and other strategies to self-manage medications at 
home need further exploration especially as some approaches 
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present more potential risk than others e.g. decanting medicines 
out of packaging into cups.  
  
Colour changes were the most challenging changes in medication 
appearance for participants to manage as colour was often a key 
element to their informal medicines management routines. Shape 
was also an important factor which similarly helped participants 
identify medications especially when some were similarly coloured 
or there were many of them to take in a day. It may be helpful for 
pharmacists and other health professionals to be aware of how 
people specifically manage their medicines at home. Such 
knowledge would of course help identify those most at risk of 
errors from poor regimes but also help those who would benefit 
from consistency in medication appearance so that their existing 
regimes continue to work for them. Emphasis would be on 
maintaining those capable of self-care to do so for as long as 
possible.    
 
This study has been valuable in that it complements our previous 
pan-Manchester survey of the same topic (Williamson et al 2009) 
which established evidence that many older people were 
experiencing anxiety, poor medicines management, upset, 
confusion, thus adding further to a very limited evidence base. 
Collectively we hope all these findings will prompt substantive 
further research into what we now believe is a widespread concern 
and problem of varying degrees amongst older people.  
 
Of immediate concern to those who develop policy or provide 
healthcare services should be that these findings clearly show that 
some older people are being put at risk due to changed medication 
appearance. Whilst medicines management has especially been 
invested in during recent years by organisations such as Primary 
Care Trusts, we suggest a closer look is taken at the extent and 
nature of the key aspect of medicines management that these 
findings highlight, namely managing changes in appearance. 
Perhaps initiatives are needed that would accurately establish the 
number and nature of changes to individual’s medication 
appearance (e.g. using pharmacy computer systems as opposed 
to patient recollection as with this study). This information could 
then be used towards identifying those patients who may be most 
vulnerable to medicines of altered appearance e.g. those 
experiencing frequent and / or multiple changes. This would be 
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complemented by having a greater appreciation of informal 
medicines management strategies used by older people at home.  
 
The implications for the roles of those who prescribe or dispense 
medicines, or those who have caring responsibilities for older 
people such as district nurses and those from partner agencies 
such as Local Authorities need to be considered. For example, 
pharmacists could seek ways of flagging up more vulnerable 
adults to GPs or possibilities for expanding the role of 
pharmaceutical home-delivery drivers could be considered. The 
widely reported good practice of pharmacists who have helped 
many respondents by sticking to a certain medication brand if the 
patient requests it is to be praised and reinforced. This good 
practice may have cost implications for the pharmacist and 
perhaps ways should be found to reimburse them. Similarly the 
approachability and helpfulness of pharmacists and their good 
practice in allaying anxiety by providing support and advice 
regarding appearance changes is worth particular mention.  
Awareness raising and education for health care professionals 
could help them to support and educate older people to manage 
medicines that change appearance more effectively. We suggest 
that multi-disciplinary work is undertaken to explore: how older 
people can be better supported to maintain their informal 
medicines management strategies; how those at risk can be better 
identified; how individual needs can be better catered for; and how 
improved information can be developed and better provided. 
Between January and March 2010 the Department of Health 
conducted a consultation on proposals to extend generic 
prescribing practices through the automated substitution of some 
branded drugs with generic ones. These study findings have been 
requested by the Department of Health and have been fed into the 
consultation.  
Finally what this study has shown is that concerns and anxiety are 
being experienced by unacceptable numbers of older people and 
we suspect that there are others who experience far greater 
effects and whom need to be engaged with in future study so that 
we can better understand their situation as a means of better 
supporting them and minimising risk.  
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Recommendations 
Study recommendations centre on future research and multiple 
agency work to: 
• Improve written information and information processes  
• Consider of the use of pictures on boxes of medications 
• Require manufacturers to notify pharmacists and explain 
changes and provide standardised packaging in terms of 
quantity (28 or 30 day packs) 
• Scope individual strategies - formal and informal - that people 
use to manage their medicines at home as a means of 
identifying risk  
• Identify training / education needs amongst primary care 
workers e.g. district nurses, pharmacists and GPs and 
partners such as Local Authorities in supporting older people 
with their medicines and identifying those most at risk e.g. 
vulnerable adults 
• Explore the frequency and nature of changes to individual’s 
medication appearance  
• Undertake economic analyses of generic prescribing 
practices including cost and quality of life implications 
• Explore the impact of changed appearance of medication 
with the wider older population including those who are less 
able to participate e.g. seldom heard or marginalised groups, 
those who are socially isolated and especially those at higher 
risk of negative effects such as those with reduced capacity 
to self manage medications 
• Devise a public information poster explaining 1) how large 
savings from generic prescribing are reinvested into patient 
services and 2) how when drugs come off patent, other 
manufacturers are free to produce them at lower cost, as 
long as they maintain efficacy 3) how pharmacists cannot 
order medicines from a specific manufacturer as it depends 
what wholesaler has in stock 4) the requirement to bulk some 
tablets up with excipients (e.g.sugars) 5) the need for 
patients to talk to their pharmacist 
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